New Procurement Policy - Essential Medicines List (EML) - Approved list of New Essential Medicines and Additional Medicines 2015
GOVERNMENT OF
ANDHRA PRADESH
ABSTRACT
New Procurement Policy -
Essential Medicines List
(EML) -
Approved list of New Essential Medicines and
Additional Medicines 2015-Orders – Issued.
HEALTH MEDICAL
AND FAMILY WELFARE (H2) DEPARTMENT
G.O.MS.No. 123
Dated:05-10-2015
Read the
following:
1. Go.Rt.No.1357, HM FW (M1) Department,
dt.19.10.2009.
2. G.O.Ms.No.204, HM & FW (M2) Dept.,
dt.17.12.2013.
3. G.O.Ms.No.101, HM & FW (M1) Dept.,
dt.29.05.2014.
4. From the MD, APMSIDC, AP., Hyderabad, File
No.40/ EML/AML
PH5/2015-16, dt.09-04-2015.
******
ORDER:
In
the letter 1st read above, the Govt. have issued the New Procurement Policy of Andhra Pradesh (2009) including the
procedure to be adopted to make available essential medicines of good quality, at
all health facilities in the State at all times, procured at competitive prices in a
transparent manner and to promote
rational use of medicines.
2. In the Government orders 2nd and 3rd read above,
the Govt. have issued orders approving a list of Essential Medicine List
and Additional medicine list and requested the M.D., A.P.M.S.I.D.C., Hyd. and other
HODs, to procure only those medicines included in the AML/EML list duly
following the procedure laid down in
the reference 1st read above.
3. In the letter 4th read above, the M.D.,
A.P.M.S.I.D.C., Hyderabad has informed that the EML list is reviewed by the
Standing Expert Committee for EML preparation. The Expert Committee, Chaired by the
Director of Medical Education, has carefully reviewed the burden of various
diseases in the state; existing protocols for treatments of various diseases; the
medicines required for the management of emergency medical problems and life
saving treatment; and costeffectiveness and efficacy of various medicines
available in the market and also held extensive consultations with pharmacologists,
clinicians, super-specialists, etc. and recommended a list of " revised Essential
Medicines" and “Additional medicine list” that satisfy the medical care needs of the
majority of the population that are safe, effective and to be made available in
adequate quantity, dosage, form and fair price, for use by all Government Hospitals, Health
Facilities and allied health institutions. After detailed discussions, the
committee prepared a revised list of new EML/AML of 2015. Further, the list needs to be
updated periodically once in 2
years in view of the rapid developments taking
place in the pharmaceutical research and new medicines being introduced in the
market on a continuous basis. He has, therefore, requested the Govt. to approve a
New EML and AML consisting of564 medicines, i.e. U-159, S-126,T-69 and AML-210
and issue orders in the matter.
4. The Government, after careful examination of the
matter herebyy accept the recommendations of the Standing Expert Committee
and hereby order that all Hospitals, Health Facilities, and other Health
Institutions under the control of HM & FW Dept., and the programmes assisted by the
Government of Andhra Pradesh
(FDHS, Epidemic, NVBDCP,SHP,APSACS) shall use only
those Medicines listed in the 'Essential Medicines List-2015(EML-2015, which in
Annexed to this order.
5. Further to address the specific requirements of
the advanced specialties and the super-specialties , the Government also approve
the 'Additional Medicines List'-2015(AML-2015) which are Annexed to this Order.
6. The medicines included in the EML2015 have been
selected through an evidence based process with due regard to
relevance, quality, safety, efficacy and comparative cost-effectiveness. These medicines
will be made available at all health facilities under the control of the Health, Medical
and Family Welfare Department.
Supply of medicines to the primary health centers
(PHCs), Urban Health Centers (UHCs) and other primary health facilities shall be
limited to those listed as 'Universal' (U) in the EML 2015. The secondary
health facilities (CHCs, Area Hospitals and Urban Dispensaries) shall utilize
those medicines listed as Universal
(U) and Secondary (S). Whereas, the tertiary
hospitals (teaching, district and super-specialty hospitals) will have access to all
drugs included in the EML 2015 as well as medicines included in AML 2015 and are for
both centralized and decentralized procurement. The medicines other than
the EML for National Disease Control Programmes, like RNTCP, NLEP, and other
requirements of state
departments like Rural Development, ICDS etc.,
shall be procured by APMSIDC based on the requirement of HOD's.
7. The Managing Director of Andhra Pradesh Health,
Medical Services and Infrastructure Development Corporation (APMSIDC)
and all Heads of the Departments under the overall charge of Health,
Medical and Family Welfare Department shall henceforth procure, store and
dispense only those medicines included in the EML and AML 2015 based on the need
under Centralized and decentralized Procurements. All medicines included
in the lists contain International Non-proprietary Names (INN) or Generic Names. The
medicines included in the list will be procured, strictly adhering to the
Pharmacopeia standards, Route of Administration, Unit Pack, Strength and
Specifications mentioned in this order.
8. All Heads of Department shall issue detailed
instructions to all facilities and functionaries under their control regarding
rational and effective use of medicines included in the EML and AML. The MD, APMSIDC shall
publish and distribute copies of the EML and AML to all health facilities and
disseminate information regarding their use amongst all health functionaries of the
state. The Commissioner of Health and Family Welfare shall organize workshops for all
medical professionals of the Health, Medical and Family Welfare Department
regarding the rational use of medicines and strict adherence to the use of
medicines listed in this Order.
9. By implementing the essential medicines concept,
the Government of Andhra Pradesh expects to improve the efficiency of drug
management in all health facilities. The Government instructed all HODs to
ensure strict compliance with the Government Orders issued in G.O.Ms No. 1357
HM&FW Department, dated 19
October 2009. All measures shall be taken by all
HODs to ensure that:
(i) All essential drugs shall be available at all
health facilities in the state at all times of the year.
(ii) Stocks required for at least three months
should be maintained at all times.
(iii) Every effort shall be made to completely
eliminate expired drugs, drug wastage, pilferage and stock-outs.
(iv) High standards of quality control and quality
assurance measures shall be maintained and monitored.
(v) All drugs in the EML and AML shall be purchased
only from pharmaceutical companies who follow good manufacturing practices
(GMP) stipulated by the drugs control authorities and APMSIDC. All
supplies will be subject to strict check in sales of Govt. and in identified
private labs of quality parameters.
(vi) No doctor of the HM&FW Department shall
procure, prescribe, dispense, or recommend any medicine that is not included in
the EML / AML without prior approval of the Government. Any violation of
these instructions shall attract disciplinary action.
(vii) A comprehensive monitoring system to ensure
that the above stipulations are fully implemented, shall be designed and
operationalized by M.D., APMISDC within three months, duly involving the
concerned Heads of Departments.
10. The M.D., A.P.M.S.I.D.C., Hyderabad and other
Heads of Department shall procure only those medicines included in the AML /
EML list duly following the procedure laid down in the reference first read
above. All hospitals under other departments of Government of Andhra Pradesh and the
private sector hospitals,
especially those included in Rajiv Aarogyasri
Network, are also strongly encouraged to use the medicines notified in this Order.
11. The Managing Director, A.P.M.S.I.D.C.,
Hyderabad, shall take necessary further action accordingly.
(BY ORDER AND IN
THE NAME OF THE GOVERNOR OF ANDHRA PRADESH)
L.V. SUBRAHMANYAM
SPL. CHIEF
SECRETARY TO GOVERNMENT
Annexure to G.O.MS.No. 123, HM&FW (H2) Dept., dt.05-10-2015 EML
S.No
|
Drug code
|
Group Name
|
Drug Name
|
Strength
|
Cate gory
|
1
|
1334
|
Anesthetics
|
Atracurium Injection 25mg/2.5ml
|
25mg/2.5ml
|
T
|
2
|
53
|
Anesthetics
|
BupivacaineHcl Hcl Injection IP 0.5%, in 20ml vial
|
0.5%
in 20ml vial
|
S
|
3
|
1697
|
Anesthetics
|
BupivacaineHcl (Spinal)
|
BupivacaineHcl Hcl Injection 0.5%
and Anhydrous Glucose or
glucose
monohydrate 80mg BP
|
S
|
4
|
666
|
Anesthetics
|
Glycopyrrolate Injection 0.2 mg / ml in 1ml amp USP
|
0.2 mg / ml in 1ml amp USP
|
S
|
5
|
315
|
Anesthetics
|
Halothane
for Inhalation (Contains Halothane BP) 250ml
|
250ml
|
S
|
6
|
355
|
Anesthetics
|
Isoflurane for Inhalation (Contains Isoflurane BP) 100ml
|
100ml
|
S
|
7
|
404
|
Anesthetics
|
Ketamine Hcl Injection IP 50mg / ml in 10-ml Vial
|
50mg / ml in 10-ml Vial
|
S
|
8
|
757
|
Anesthetics
|
Lignocaine Hcl Gel IP 2% in 30 gms tube
|
2% in 30 gms tube
|
U
|
9
|
420
|
Anesthetics
|
Lignocaine and Adrenaline Injection IP (Contains Lignocaine
Hcl 2% and Adrenaline 1:200
000) in 30 ml Vial
|
(Contains Lignocaine Hcl 2% and Adrenaline
1:200 000) in 30 ml
Vial
|
S
|
10
|
1857
|
Anesthetics
|
Lignocaine Eye Drops BP 4 % in 5ml vial
|
4 % in 5ml
|
S
|
11
|
417
|
Anesthetics
|
Lignocaine Hcl Injection IP 5% in
2ml ampoule
|
5% in 2ml ampoule
|
U
|
12
|
409.01
|
Anesthetics
|
Lignocaine Hcl Injection 2% in 30 ml Vial
|
2% in 30 ml Vial
|
U
|
13
|
1829
|
Anesthetics
|
Midazolam Inj 1mg/ml 10ml
|
Inj 1mg/ml
10ml
|
S
|
14
|
1323
|
Anesthetics
|
Propofol Injection BP 1% in 20ml vial
|
1% in 20ml vial
|
S
|
15
|
1326
|
Anesthetics
|
Sevoflurane for Inhalation in 250ml bottle (contains Sevoflurane
)(USP)
|
250ml
bottle
|
T
|
16
|
664
|
Anesthetics
|
Thiopentone Sodium Injection IP 0.5gm
/ml
|
0.5gm
/ml
|
S
|
17
|
672
|
Anesthetics
|
Timolol Maleate eye Drops IP 0.25%, 5 ml
|
0.25%, 5 ml
|
S
|
18
|
1908
|
Anesthetics
|
Trichlofos BP 500mg/5ml BP
|
500mg/5ml BP
|
T
|
19
|
2119
|
Analgesic And Antipyretic
|
Paracetamol Solution for Infusion (10mg/ml) in 100ml glass bottle i.e.1gm/100ml BFS/FFS
|
1gm/100ml
|
S
|
20
|
2091
|
Analgesic And Muscle Relaxant
|
Flupirtine Maleate Capsules 100mg
|
100mg
|
S
|
21
|
40.02
|
Analgesic, Antipyretic & Anti-
Inflammatory Drugs
|
Acetyl Salicylic Acid Tablets IP 150mg
|
150mg
|
U
|
22
|
197
|
Analgesic, Antipyretic &
Anti-
Inflammatory Drugs
|
Diclofenac Sodium 50mg Tablets IP (Enteric coated Tablets)
|
50mg
|
U
|
23
|
198
|
Analgesic, Antipyretic &
Anti- Inflammatory Drugs
|
Diclofenac Sodium Injection IP25 mg / ml in 3ml ampoule
|
25 mg / ml in 3ml ampoule
|
U
|
24
|
2080
|
Analgesic, Antipyretic & Anti- Inflammatory Drugs
|
Diclofenac Sodium Tab100mg SR
|
100mg
SR
|
S
|
25
|
1804
|
Analgesic, Antipyretic &
Anti- Inflammatory Drugs
|
Fentanyl Inj. 100mcg/2ml
|
100mcg/2ml
|
T
|
26
|
1865
|
Analgesic, Antipyretic & Anti-
Inflammatory Drugs
|
Mefenamic acid Tablets BP 500 mg
|
500 mg
|
T
|
27
|
525
|
Analgesic, Antipyretic &
Anti-
Inflammatory Drugs
|
Paracetamol Tablets IP 500 mg
|
500 mg
|
U
|
28
|
527.01
|
Analgesic, Antipyretic & Anti-
Inflammatory Drugs
|
Paracetamol Injection 300mg in 2ml
|
300mg
in 2ml
|
U
|
29
|
1701
|
Analgesic, Antipyretic &
Anti-
Inflammatory Drugs
|
Paracetamol Syrup IP (Non Alcohol based) 125 mg / 5 ml in 60ml
|
125
mg / 5 ml in 60ml
|
U
|
30
|
582
|
Analgesic, Antipyretic &
Anti- Inflammatory Drugs
|
Pentazocine lactate Injection IP30 mg / ml in 1ml Amp
|
30 mg / ml in 1ml Amp
|
U
|
31
|
1325
|
Analgesic, Antipyretic & Anti- Inflammatory Drugs
|
Serratiopeptidase tablets IP 10mg
|
10mg
|
U
|
32
|
1329
|
Analgesic, Antipyretic &
Anti- Inflammatory Drugs
|
Tramadol Injection Each ml Contains Tramadol Hcl BP 100 mg /2ml
|
100
mg /2ml
|
S
|
33
|
2093
|
Anti Bacterial
|
Fucidin Cream 20gm
|
20gm
|
U
|
34
|
2103
|
Anti Cancer
|
Trastuzumab Inj. (r-DNA Origin) 440mg vial
|
440mg
|
T
|
35
|
2012
|
Anti Depressant
|
Sertraline Tab 50mg
|
50mg
|
T
|
36
|
2074
|
Anti Fungal
|
Clobetasol Cream 0.05% 10gm
|
0.05%
10gm
|
S
|
37
|
2143
|
Anti Hypertensive
|
Frusemide 20mg
+ Spironolactone 50mg
|
Frusemide 20mg
+ Spironolactone 50mg
|
S
|
38
|
1832
|
Anti Malarial
|
Artisunate Inj. 60mg/ml 2ml vial
|
60mg/ml 2ml vial
|
U
|
39
|
107
|
Anti Malarial
|
Chloroquine Phosphate
Injection IP 40 mg / ml
in 3ml amp
|
40 mg / ml in 3ml amp
|
U
|
40
|
1625
|
Anti Malarial
|
Chloroquine Phosphate Syrup 50 mg / 5 ml in 60ml
|
50 mg / 5 ml in 60ml
|
U
|
41
|
106
|
Anti Malarial
|
Chloroquine Phosphate
Tablets IP 250 mg base(Equivalent to
155 mg of Chloroquine )
|
250 mg
base(Equivalent to 155 mg of Chloroquine )
|
U
|
42
|
2097
|
Anti Malarial
|
Hydroxy Chloroquine Tab 200mg
|
200mg
|
S
|
43
|
1866
|
Anti Malarial
|
Mefloquine Hcl IP Tablets 250mg
|
250mg
|
T
|
44
|
1519
|
Anti Malarial
|
Primaquine Tablets IP 7.5 mg
|
7.5 mg
|
U
|
45
|
1521
|
Anti Malarial
|
Primaquine Tablets IP 2.5 mg
|
2.5 mg
|
U
|
46
|
1474
|
Anti Malarial
|
Sulfadoxine + Pyrimethamine 500 mg Sulfadoxine + 25 mg Pyrimethamine Tablets IP
|
Sulfadoxine + Pyrimethamine 500 mg Sulfadoxine + 25 mg Pyrimethamine Tablets IP
|
U
|
47
|
1875
|
Anti Neoplastic And Immuno Suppressant Medicines
|
Methotrexate Injection IP 50 mg / ml in 2ml amp
|
50 mg / ml in 2ml amp
|
T
|
48
|
1749
|
Anti Parkinsonism
|
Cabergoline Tablets 0.5mg
|
0.5mg
|
T
|
49
|
1172
|
Anti Parkinsonism
|
Trihexyphenidyl Hcl Tablets IP 2mg
|
2mg
|
S
|
50
|
1643
|
Anti Protozoal
|
Metronidazole benzoate Oral Suspention IP 100mg/5ml in
60ml
|
100mg/5ml in 60ml
|
U
|
51
|
440
|
Anti Protozoal
|
Metronidazole IV Infusion IP 500mg in 100 ml
|
500mg
in 100 ml
|
U
|
52
|
1642
|
Anti Protozoal
|
Metronidazole Tablets IP Film coated 200 mg
|
200 mg
|
U
|
53
|
252
|
Anti Retro Viral
|
Enalapril Tab 10mg
|
10 mg
|
S
|
54
|
2160
|
Anti Retro Viral
|
Tenofovir Tab 300mg
|
300mg
|
S
|
55
|
1290
|
Antiallergics & Drugs Used In Anaphylaxis
|
Adrenaline Bitartrate Injection IP 1 mg / ml in 1ml Amp
|
1 mg / ml in 1ml Amp
|
U
|
56
|
1123
|
Antiallergics & Drugs Used In Anaphylaxis
|
Cetirizine Hcl Tablets IP 10mg
|
10mg
|
U
|
57
|
1626
|
Antiallergics & Drugs Used In Anaphylaxis
|
Chlorpheniramine Maleate Syrup 2 mg / 5ml in 60ml bottle
|
2 mg / 5ml in 60ml bottle
|
U
|
58
|
741
|
Antiallergics & Drugs Used In Anaphylaxis
|
Chlorpheniramine Maleate Tablets IP 4 mg
|
4 mg
|
U
|
59
|
221.02
|
Antiallergics & Drugs Used In Anaphylaxis
|
Dexamethasone Injection IP 8 mg / 2ml
|
8 mg / 2ml
|
U
|
60
|
1300
|
Antiallergics & Drugs Used In Anaphylaxis
|
Hydrocortisone
Sodium Succinate Injection IP contains Hydrocortisone 100 mg/in 5ml
vial
|
100
mg/in 5ml vial
|
U
|
61
|
1310
|
Antiallergics & Drugs Used In
Anaphylaxis
|
Methyl Prednisolone acetate Inj. IP 500mg
|
500mg
|
T
|
62
|
579
|
Antiallergics & Drugs Used In
Anaphylaxis
|
Pheniramine Maleate Injection IP 22.75 mg / ml in 2ml amp
|
22.75 mg / ml in 2ml amp
|
U
|
63
|
576
|
Antiallergics & Drugs Used In
Anaphylaxis
|
Prednisolone Tablets IP 5mg
|
5mg
|
U
|
64
|
566
|
Antiallergics & Drugs Used In Anaphylaxis
|
Promethazine Hcl Injection IP 25 mg / ml in 2ml ampoule
|
25 mg / ml in 2ml ampoule
|
U
|
65
|
564.01
|
Antiallergics & Drugs Used In Anaphylaxis
|
Promethazine Hcl Syrup IP 5 mg / 5 ml in 60ml
|
5 mg / 5 ml in 60ml
|
U
|
66
|
1479
|
Antibacterial
|
Acyclovir Injection 250mg
|
250mg
|
T
|
67
|
1188
|
Antibacterial
|
Amikacin Sulphate
Injection IP sulphate 100 mg / 2 ml
|
100 mg / 2 ml
|
S
|
68
|
1189
|
Antibacterial
|
Amikacin Sulphate
Injection IP sulphate 500 mg / 2 ml
|
500 mg / 2 ml
|
S
|
69
|
6
|
Antibacterial
|
Amoxicillin Capsules IP 250 mg
|
250 mg
|
U
|
70
|
7
|
Antibacterial
|
Amoxicillin Capsules IP 500 mg
|
500 mg
|
U
|
71
|
8
|
Antibacterial
|
Amoxicillin oral suspension IP 125 mg / 5 ml in 30ml
|
125
mg / 5 ml in 30ml
|
U
|
72
|
1342
|
Antibacterial
|
Amoxycillin +Clavulanic Acid Oral Suspension
|
Amoxycillin and Potassium Clavulanate Oral Suspension I.P. Amoxycillin 200 mg/5 ml + Potassium Clavulanate 28.5mg/5 ml in 30ml bottle
|
U
|
73
|
1347
|
Antibacterial
|
Amoxycillin 1gm + 200mg Clavulanic Acid Injection
|
1 gm Amoxycillin + 200mg Potassium
Clavulanate Injection
I.P.
|
S
|
74
|
1341
|
Antibacterial
|
Amoxycillin 250mg
+125mg Clavulanic Acid Tablets
|
250
mg Amoxycillin
+125 mg Potassium Clavulanate Tablets
|
S
|
75
|
1340
|
Antibacterial
|
Amoxycillin 500mg
+125mg Clavulanic Acid Tablets
|
500 mg Amoxycillin + 125 mg Potassium Clavulanate Tablets
IP
|
U
|
76
|
1
|
Antibacterial
|
Ampicillin
Injection IP 500 mg vial
|
500
mg vial
|
U
|
77
|
1477
|
Antibacterial
|
Azithromycin Tablets IP 500 mg
|
500 mg
|
U
|
78
|
1699
|
Antibacterial
|
Azithromycin Dispersible tablet 100 mg
|
100 mg
|
S
|
79
|
1622
|
Antibacterial
|
Cefixime Tablets IP 200 mg
|
200 mg
|
U
|
80
|
1621
|
Antibacterial
|
Cefixime Dispersible tablet USP 100 mg
|
100 mg
|
U
|
81
|
1719
|
Antibacterial
|
Cefoperazon 1gm + Sulbactum 500mg
|
1 gm Cefoperazone + 500 mg Sulbactum Injection
|
T
|
82
|
1355
|
Antibacterial
|
Cefotaxime Sodium Injection IP 1000 mg
|
1000
mg
|
U
|
83
|
1527
|
Antibacterial
|
Cefotaxime Sodium Injection IP 250mg
|
250mg
|
S
|
84
|
1381
|
Antibacterial
|
Ceftazidime Inj IP 1gm
|
1gm
|
T
|
85
|
1360
|
Antibacterial
|
Ceftriaxone Injection IP 1gm
|
1gm
|
S
|
86
|
1752
|
Antibacterial
|
Cefuroxime Injection IP 250 mg
|
250 mg
|
T
|
87
|
1751
|
Antibacterial
|
Cefuroxime Injection IP 750 mg
|
750 mg
|
T
|
88
|
94
|
Antibacterial
|
Ciprofloxacin Tablets IP 500 mg
|
500 mg
|
U
|
89
|
95
|
Antibacterial
|
Ciprofloxacin Injection IP 200mg/100ml BFS / FFS
|
200mg/100ml
|
U
|
90
|
1671
|
Antibacterial
|
Clotrimazole Cream IP 2% 30gm
|
30gm
|
U
|
91
|
1389
|
Antibacterial
|
Clotrimazole Pessaries IP 100 mg
|
100 mg
|
U
|
92
|
97
|
Antibacterial
|
Cotrimaxazole Tabs. IP 160mg+800mg (Trimethoprim+Sulphamethoxaz
ole)
|
160mg
+ 800 mg
|
U
|
93
|
98
|
Antibacterial
|
Cotrimaxazole Syrup IP. 40mg+200mg
|
Co-trimoxazole oral suspension I.P Trimethoprim40mg
+ sulphamethoxazole 200mg/5ml in 50ml bottle
|
U
|
94
|
192
|
Antibacterial
|
Doxycycline Hcl Capsule IP 100 mg
|
100 mg
|
U
|
95
|
1192
|
Antibacterial
|
Erythromycin Tab
500mg
|
500mg
|
S
|
96
|
294.01
|
Antibacterial
|
Gentamicin Injection IP 40 mg / ml in 2ml Vial
|
40 mg / ml in 2ml Vial
|
U
|
97
|
1630
|
Antibacterial
|
Griseofulvin Tablets IP 250 mg
|
250 mg
|
T
|
98
|
308
|
Antibacterial
|
Griseofulvin Tablets IP 125 mg
|
125 mg
|
S
|
99
|
1724
|
Antibacterial
|
Linezolid Tablets IP 600 mg
|
600 mg
|
S
|
100
|
1700
|
Antibacterial
|
Meropenam Injection IP 1gm for vial
|
1gm
for vial
|
T
|
101
|
438.01
|
Antibacterial
|
Metronidazole Tablets IP 400 mg (Film Coated )
|
400 mg
|
U
|
102
|
1896
|
Antibacterial
|
Nitrofurantoin Tablets IP 100 mg
|
100 mg
|
S
|
103
|
482
|
Antibacterial
|
Norfloxacin Tablets IP 400mg
|
400mg
|
U
|
104
|
1902
|
Antibacterial
|
Ofloxacin Tablets 100mg
|
100mg
|
S
|
105
|
1528
|
Antibacterial
|
Ofloxacin Tablets IP 200 mg
|
200 mg
|
T
|
106
|
1702
|
Antibacterial
|
Ofloxacin Suspension 50 mg /5 ml , 60 ml
|
50 mg /5 ml
, 60 ml
|
U
|
107
|
1652
|
Antibacterial
|
Piperacillin + tazobactum Injection 4gm +0.5gm
|
Piperacillin + Tazobactum Injection 4gm +0.5gm
|
T
|
108
|
1830
|
Antibacterial
|
Vancomycin Intravenous Infusion IP Inj 1gm Vial
|
1gm Vial
|
T
|
109
|
136
|
Anticonvulsants
/ Antiepileptic
|
Carbmazepine Tablets (Film coated) 100mg
|
100mg
|
S
|
110
|
1441
|
Anticonvulsants
/
|
Magnesium Sulphate Injection IP 500 mg /ml, in 2ml ampoule
|
500 mg /ml, in 2ml ampoule
|
U
|
111
|
752
|
Antiepileptic
|
Phenytoin sodium Injection IP 50mg/ml in 5ml vial
|
50mg/ml in 5ml vial
|
S
|
112
|
1651
|
Anticonvulsants
/
|
Phenytoin sodium Syrup 25mg/5ml 60ml bottle
|
25mg/5ml 60ml bottle
|
S
|
113
|
1167
|
Antiepileptic
|
Phenytoin sodium Tablets IP 100mg
|
100mg
|
S
|
114
|
2169
|
Antidote For Snake Poisoning
|
Snake Venum Anti
Serum IP Liquid Form
|
Snake
Venum Anti Serum IPLiquid Form Polyvalent Anti Snake Venum,
10 ml Vial Serum Enzyme Refined. Contain Equivalent of Purified Equine Globulins, 1ml of Reconstituted Serum Neutralizes 0.6mg of Dried Cobra Naja-Naja Venom. 0.45mg
of The Dried Common Kraite Bungaral
|
T
|
115
|
1730
|
Antidotes And Other
Substances Used In Poisoning
|
Activated Charcoal IP (Powder) 500gm
|
500gm
|
T
|
116
|
632
|
Antidotes And Other Substances Used In Poisoning
|
Antisnake Venom Injection
|
Snake
Venom Antiserum I.P. Polyvalent, Enzyme Refined, Equine Immunoglobulin. Each 1ml upon reconstitution to 10ml with water for injection neutralizes not less than 0.60mg.Of dried Indian cobra(naja naja
)Venom 0.45mg. Of dried, common krait(Bungaruscaerule
us)Venom 0.60mg. Of dried, Russell's viper(baoia russelli)
venom 0.45mg. of driedawsealedvipes(Ec hiscartinatus)venom
|
U
|
117
|
2066
|
Antidotes And Other Substances Used In Poisoning
|
Atropine sulphate injection 0.6%, 10ml vials
|
10ml
vials
|
U
|
118
|
1693
|
Antidotes And Other
Substances Used In Poisoning
|
Atropine Sulphate
Injection IP
0.6 mg / ml
|
0.6
mg / ml
|
U
|
119
|
1265
|
Antidotes And Other Substances Used In Poisoning
|
Pralidoxime Chloride (2-PAM)
|
Pralidoxime Chloride (2-PAM)
Injection IP 1 grm Lyophilized Vials with diluents 20ml amp
|
U
|
120
|
1200
|
Anti-infective
|
Albendazole Suspension 200 mg/ 5 ml in 10ml bottle
|
200 mg/
5 ml in 10ml bottle
|
U
|
121
|
736
|
Anti infective
|
Albendazole Tablets (Chewable) IP 400 mg
|
400 mg
|
U
|
122
|
201
|
Anti infective
|
Diethylcarbamazine Citrate Tablets IP 100mg
|
100mg
|
U
|
123
|
1846
|
Anti infective
|
Ivermectin Tablets USP 3mg
|
3mg
|
T
|
124
|
1914
|
Anti infective
|
Praziquantel Tablets IP 600
mg
|
600 mg
|
T
|
125
|
1613
|
Antiviral
|
Aciclovir Ointment USP 5% 10 gm tube
|
10 gm tube
|
S
|
126
|
1691
|
Antiviral
|
Aciclovir Tablets IP 400 mg
|
400 mg
|
S
|
127
|
2062
|
Cardio Vascular
|
Acetyl Salicylic acid Tab 75mg
|
75mg
|
U
|
Post a Comment